676
Views
16
CrossRef citations to date
0
Altmetric
PAPERS

Direct visualization of phase separation induced by phenothiazine-type antipsychotic drugs in model lipid membranes

, &
Pages 103-114 | Received 23 Jul 2010, Accepted 13 Sep 2010, Published online: 29 Dec 2010

References

  • de Almeida RFM, Loura LMS, Fedorov A, Prieto M. 2005. Lipid rafts have different sizes depending on membrane composition: A time-resolved fluorescence resonance energy transfer study. J Mol Biol 346:1109–1120.
  • Angelova MI, Dimitrov DS. 1986. Liposome electroformation. Faraday Discuss Chem Soc 81:303–308.
  • Arcaro A, Aubert M, Espinosa del Hierro ME, Khanzada UK, Angelidou S, Tetley TD, Bittermann AG, Frame MC, Seckl MJ. 2007. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signaling. Cell Signal 19:1081–1092.
  • Bagatolli LA, Parasassi T, Fidelio GD, Gratton E. 1999. A model for the interaction of 6-lauroyl-2-(N,N-dimethylamino)naphthalene with lipid environments: Implications for spectral properties. Photochem Photobiol 70:557–564.
  • Bagatolli LA. 2006. To see or not to see: Lateral organization of biological membranes and fluorescence microscopy. Biochim Biophys Acta 1758:1541–1556.
  • Baumgart T, Hunt G, Farkas ER, Webb WW, Feigenson GW. 2007. Fluorescence probe partitioning between Lo/Ld phases in lipid membranes. Biochim Biophys Acta 1768:2182–2194.
  • Brown DA, London E. 1998. Structure and origin of ordered lipid domains in biological membranes. J Membr Biol 164:103–114.
  • Cruzeiro-Hansson L, Ibsen JH, Mouritsen OG. 1989. Intrinsic molecules in lipid membranes change the lipid-domain interfacial area: Cholesterol at domain interfaces. Biochim Biophys Acta 979:166–176.
  • Dean DS, Manghi M. 2006. Fluctuation-induced interactions between domains in membranes. Phys Rev E 74:021916.
  • Dietrich C, Bagatolli LA, Volovyk ZN, Thompson NL, Levi M, Jacobson K, Gratton E. 2001. Lipid rafts reconstituted in model membranes. Biophys J 80:1417–1428.
  • Dimitrov DS, Angelova MI. 1988. Lipid swelling and liposome formation mediated by electric fields. Bioelectrochem Bioenerg 19:323–333.
  • Eisensamer B, Uhr M, Meyr S, Gimpl G, Deiml T, Rammes G, Lambert JJ, Zieglgansberger W, Holsboer F, Rupprecht R. 2005. Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains. J Neurosci 25:10198–10206.
  • Fenton M, Rathbone J, Reilly J, Sultana A. 2007. Thioridazine for schizophrenia. Cochrane Database Syst Rev 3:CD001944.
  • Freeman MR, Cinar B, Lu ML. 2005. Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer. Trends Endocrinol Metab 16:273–279.
  • Garcia-Saez AJ, Chiantia S, Schwille P. 2007. Effect of line tension on the lateral organization of lipid membranes. J Biol Chem 282:33537–33544.
  • Heerklotz H, Szadkowska H, Anderson T, Seelig J. 2003. The sensitivity of lipid domains to small perturbations demonstrated by the effect of Triton. J Mol Biol 329:793–799.
  • Hendrich AB, Wesolowska O, Michalak K. 2001. Trifluoperazine induces domain formation in zwitterionic phosphatidylcholine but not in charged phosphatidylglycerol bilayers. Biochim Biophys Acta 1510:414–425.
  • Hendrich AB, Wesolowska O, Komorowska M, Motohashi N, Michalak K. 2002. The alterations of lipid bilayer fluidity induced by newly synthesized phenothiazine derivative. Biophys Chem 98:275–285.
  • Hendrich AB, Michalak K, Wesolowska O. 2007. Phase separation is induced by phenothiazine derivatives in phospholipid/sphingomyelin/cholesterol mixtures containing low levels of cholesterol and sphingomyelin. Biophys Chem 130:32–40.
  • Jorgensen K, Ipsen JH, Mouritsen OG, Bennett D, Zuckermann MJ. 1991. A general model for the interaction of foreign molecules with lipid membranes: Drugs and anaesthetics. Biochim Biophys Acta 1062:227–238.
  • Jorgensen K, Ipsen JH, Mouritsen OG, Bennett D, Zuckermann MJ. 1993. The effect of anaesthetics on the dynamic heterogeneity of lipid membranes. Chem Phys Lipids 65:205–216.
  • Juhasz J, Sharom FJ, Davis JH. 2009. Quantitative characterization of coexisting phases in DOPC/DPPC/cholesterol mixtures: Comparing confocal fluorescence microscopy and deuterium nuclear magnetic resonance. Biochim Biophys Acta 1788:2541–2552.
  • Jutila A, Soderlund T, Pakkanen AL, Huttunen M, Kinnunen PK. 2001. Comparison of the effects of clozapine, chlorpromazine, and haloperidol on membrane lateral heterogeneity. Chem Phys Lipids 112:151–163.
  • Leucht C, Kitzmantel M, Chua L, Kane J, Leucht S. 2008. Haloperidol versus chlorpromazine for schizophrenia. Cochrane Database Syst Rev 1:CD004278.
  • Lingwood D, Simons K. 2010. Lipid rafts as a membrane-organizing principle. Science 327:46–50.
  • Marques LO, Lima MS, Soares BG. 2004. Trifluoperazine for schizophrenia. Cochrane Database Syst Rev 1:CD003545.
  • Mouritsen OG, Jorgensen K. 1992. Dynamic lipid-bilayer heterogeneity: A mesoscopic vehicle for membrane function? BioEssays 14:129–136.
  • Mouritsen OG, Jorgensen K. 1994. Dynamic order and disorder in lipid bilayer. Chem Phys Lipids 73:3–25.
  • Mukherjee S, Chattopadhyay A. 2005. Monitoring the organization and dynamics of bovine hippocampal membranes utilizing Laurdan generalized polarization. Biochim Biophys Acta 1714:43–55.
  • Parasassi T, De Stasio G, d'Ubaldo A, Gratton E. 1990. Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence. Biophys J 57:1179–1186.
  • Parasassi T, Di Stefano M, Loiero M, Ravagnan G, Gratton E. 1994. Influence of cholesterol on phospholipid bilayers phase domains as detected by Laurdan fluorescence. Biophys J 66:120–132.
  • Parasassi T, Gratton E. 1995. Membrane lipid domains and dynamics as detected by Laurdan fluorescence. J Fluorescence 5:59–69.
  • Pata V, Dan N. 2005. Effect of membrane characteristics on phase separation and domain formation in cholesterol-lipid mixtures. Biophys J 88:916–924.
  • Roche Y, Gerbeau-Pissot P, Buhot B, Thomas D, Bonneau L, Gresti J, Mongrand S, Perrier-Cornet JM, Simon-Plas F. 2008. Depletion of phytosterols from the plant plasma membrane provides evidence for disruption of lipid rafts. FASEB J 22:3980–3991.
  • Ruckerl F, Kas JA, Selle C. 2008. Diffusion of nanoparticles in monolayers is modulated by domain size. Langmuir 24:3365–3369.
  • Semrau S, Idema T, Schmidt T, Storm C. 2009. Membrane-mediated interactions measured using membrane domains. Biophys J 96:4906–4915.
  • Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387:569–572.
  • Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39.
  • Simons K, Vaz WLC. 2004. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 33:269–295.
  • Soderlund T, Lehtonen JY, Kinnunen PK. 1999. Interactions of cyclosporin A with phospholipid membranes: Effect of cholesterol. Mol Pharmacol 55:32–38.
  • Suwalsky M, Villena F, Sotomayor CP, Bolognin S, Zatta P. 2008. Human cells and cell membrane molecular models are affected in vitro by chlorpromazine. Biophys Chem 135:7–13.
  • Takegami S, Kitamura K, Kitade T, Hasegawa K, Nishihira A. 1999. Effects of particle size and cholesterol content on the partition coefficients of chlorpromazine and trifluoperazine between phosphatidylcholine-cholesterol bilayers of unilamellar vesicles and water studied by second-derivative spectrophotometry. J Colloid Interf Sci 220:81–87.
  • Tarahovsky YS, Muzafarov EN, Kim YA. 2008. Rafts making and rafts braking: How plant flavonoids may control membrane heterogeneity. Mol Cell Biochem 314:65–71.
  • Tessier C, Nuss P, Staneva G, Wolf C. 2008. Modification of membrane heterogeneity by antipsychotic drugs: An X-ray diffraction comparative study. J Colloid Interf Sci 320:469–475.
  • Thirumoorthy K, Nandi N, Vollhardt D. 2007. Role of dipolar interaction in the mesoscopic domains of phospholipid monolayers: Dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylethanolamine. Langmuir 23:6991–6996.
  • Ursell TS, Klug WS, Phillips R. 2009. Morphology and interaction between lipid domains. Proc Natl Acad Sci USA 106:13301–13306.
  • Veatch SL, Leung SS, Hancock RE, Thewalt JL. 2007. Fluorescent probes alter miscibility phase boundaries in ternary vesicles. J Phys Chem 111:502–504.
  • Wenz JJ, Barrantes FJ. 2003. Steroid structural requirements for stabilizing or disrupting lipid domains. Biochemistry 42:14267–14276.
  • Wesolowska O, Michalak K, Maniewska J, Hendrich AB. 2009. Giant unilamellar vesicles – a perfect tool to visualize phase separation and lipid rafts in model systems. Acta Biochim Pol 56:33–39.
  • Wisniewska A, Wolnicka-Glubisz A. 2004. ESR studies on the effect of cholesterol on chlorpromazine interaction with saturated and unsaturated liposome membranes. Biophys Chem 11:43–52.
  • Yanagisawa M, Imai M, Masui T, Komura S, Ohta T. 2007. Growth dynamics of domains in ternary fluid vesicles. Biophys J 92:115–125.
  • Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR. 2005. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cell and xenografts. J Clin Invest 115:959–968.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.